Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+11.0%/yr
vs -6.0%/yr prior
5Y CAGR
+10.4%/yr
Consistent
Acceleration
+17.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $268.09M | +60.4% |
| 2024 | $167.13M | +27.3% |
| 2023 | $131.31M | -33.1% |
| 2022 | $196.25M | -18.8% |
| 2021 | $241.54M | +47.7% |
| 2020 | $163.56M | +36.0% |
| 2019 | $120.28M | -52.2% |
| 2018 | $251.45M | +78.2% |
| 2017 | $141.10M | +29.5% |
| 2016 | $108.97M | - |